Biotia, a company advancing infectious disease diagnostics for challenging infections, today announced the publication of a pivotal clinical validation study in the American Society for Microbiology ...

A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...

Ada Health, a leading clinical AI company that helps people understand their symptoms and navigate care safely and ...

Peer-reviewed medical research, published by the New England Journal of Medicine and the JAMA Network, will be accessible ...

Explore the economic and logistical factors driving prescription drug shortages and their impact on global patient care.

This randomized, double-blind, placebo-controlled, single ascending-dose study evaluated oral doses of the botanical kratom ...

Personalized guidance about the appropriate amount and type of physical activity for children with heart conditions relies on diagnosis, individual risk profile and personal and family goals. Ongoing ...

The Providence Journal and United Way of Rhode Island have partnered to highlight the state's nonprofits. Each week, a ...

Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their ...

Rising imaging demand and workforce shortages drive simulation adoption in diagnostic radiography education, enhancing ...

More than 2,000 academic papers have cited or based some of their content on fictional case studies that have now been ...

Comprehensive review led by R3’s Department of Research consolidates emerging evidence on Wharton’s jelly function, ...